Francisco Javier Novo Villaverde-rekin lankidetzan egindako argitalpenak (24)

2013

  1. CBL RING finger deletions are common in core-binding factor acute myeloid leukemias

    Leukemia and Lymphoma

2010

  1. A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes

    Cancer Genetics and Cytogenetics, Vol. 199, Núm. 1, pp. 1-8

  2. Quantification of PDGFRA alternative transcripts improves the screening for XPDGFRA fusions by reverse transcriptase-polymerase chain reaction

    Leukemia and Lymphoma, Vol. 51, Núm. 9, pp. 1720-1726

  3. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

    Blood, Vol. 115, Núm. 3, pp. 615-625

2008

  1. Low frequency of JAK2 exon 12 mutations in classic and atypical CMPDs

    Leukemia Research

  2. Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms

    Leukemia Research

2005

  1. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas

    Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423

  2. FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome

    Human Genetics, Vol. 116, Núm. 6, pp. 476-485

2004

  1. NIN, a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to PDGFRB in a Patient with a t(5;14)(q33;q24) and an Imatinib-Responsive Myeloproliferative Disorder

    Cancer Research, Vol. 64, Núm. 8, pp. 2673-2676

  2. Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion [5]

    Cancer Genetics and Cytogenetics

2003

  1. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients

    Oncogene, Vol. 22, Núm. 7, pp. 1070-1072

  2. TP53 Is Frequently Altered by Methylation, Mutation, and/or Deletion in Acute Lymphoblastic Leukaemia

    Molecular Carcinogenesis, Vol. 38, Núm. 4, pp. 201-208

  3. t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia

    Genes Chromosomes and Cancer, Vol. 36, Núm. 4, pp. 402-405

2002

  1. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome

    Genes Chromosomes and Cancer, Vol. 35, Núm. 1, pp. 11-19

  2. Cancer epigenetics and methylation [3] (multiple letters)

    Science

  3. Citogenética y biología molecular en la leucemia aguda linfoblástica

    Haematologica, Vol. 87, Núm. supl. 1, pp. 185-194

  4. Exon concatenation to increase the efficiency of mutation screening by DGGE

    BioTechniques, Vol. 32, Núm. 5, pp. 1064-1070

  5. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci

    International Journal of Cancer, Vol. 98, Núm. 3, pp. 470-474

  6. Multicolor-FICTION: Expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses

    American Journal of Pathology, Vol. 161, Núm. 2, pp. 413-420

  7. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma

    Blood, Vol. 99, Núm. 4, pp. 1474-1477